Connect Biopharma (CNTB) Director Jean Liu Receives 8,984 Shares

What Happened

• Jean Liu, a director of Connect Biopharma Holdings Ltd (CNTB), was granted 8,984 fully vested ordinary shares on 2026-09-30 as director compensation. The grant is recorded as an award/acquisition at an acquisition price of $0 (shares issued in lieu of cash).

Key Details

• Transaction date: 2026-09-30 (reported on Form 4 filed 2026-10-01).
• Transaction type: Award/Grant (A); acquisition price listed as $0 because shares were issued instead of cash.
• Shares acquired: 8,984 fully vested ordinary shares.
• Shares owned after transaction: Not specified in the provided filing details.
• Footnote: Ms. Liu elected to receive fully vested shares instead of cash for her 2026 annual board retainer. The share count was determined by dividing the equity value by the average closing price of CNTB ordinary shares for the 30 days ending Sept 30, 2026, rounded down.
• Filing timeliness: Form 4 was filed within the standard reporting window (appears timely).

Context

• This was a compensation grant, not an open-market purchase or sale—such grants are routine for non-employee directors and reflect compensation policy rather than a direct buy/sell signal.
• Because the shares are fully vested, there is no future vesting schedule tied to this grant.